Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01723839
Brief Title: Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide (FCR)

First Submitted : November 6, 2012
First Submitted that Met QC Criteria : November 7, 2012
First Posted : November 8, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : October 4, 2019
Last Update Posted : October 7, 2019